Literature DB >> 6020842

Proflavine and acriflavine.

C H Browning.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6020842      PMCID： PMC1841252          DOI： 10.1136/bmj.2.5544.111-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  1 in total

1.  A chemist's view of cancer prevention.

Authors:  E Boyland
Journal:  Proc R Soc Med       Date:  1967-01
  1 in total
  3 in total

1.  Parallel screening of wild-type and drug-resistant targets for anti-resistance neuraminidase inhibitors.

Authors:  Kai-Cheng Hsu; Hui-Chen Hung; Jim-Tong Horng; Ming-Yu Fang; Chun-Yu Chang; Ling-Ting Li; I-Jung Chen; Yun-Chu Chen; Ding-Li Chou; Chun-Wei Chang; Hsing-Pang Hsieh; Jinn-Moon Yang; John T-A Hsu
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

2.  Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses.

Authors:  Valeria Napolitano; Agnieszka Dabrowska; Kenji Schorpp; André Mourão; Emilia Barreto-Duran; Malgorzata Benedyk; Pawel Botwina; Stefanie Brandner; Mark Bostock; Yuliya Chykunova; Anna Czarna; Grzegorz Dubin; Tony Fröhlich; Michael Hölscher; Malwina Jedrysik; Alex Matsuda; Katarzyna Owczarek; Magdalena Pachota; Oliver Plettenburg; Jan Potempa; Ina Rothenaigner; Florian Schlauderer; Klaudia Slysz; Artur Szczepanski; Kristin Greve-Isdahl Mohn; Bjorn Blomberg; Michael Sattler; Kamyar Hadian; Grzegorz Maria Popowicz; Krzysztof Pyrc
Journal:  Cell Chem Biol       Date:  2022-01-11       Impact factor: 9.039

3.  Activation of cGAS-dependent antiviral responses by DNA intercalating agents.

Authors:  Geneviève Pépin; Charlotte Nejad; Belinda J Thomas; Jonathan Ferrand; Kate McArthur; Philip G Bardin; Bryan R G Williams; Michael P Gantier
Journal:  Nucleic Acids Res       Date:  2016-09-29       Impact factor: 16.971
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.